4893 items matching your search terms.

Minimally invasive medial patellofemoral ligament reconstruction for patellar instability using an artificial ligament: a two year follow-up

Khemka, A. Lord, S. J. Doyle, Z. Bosley, B. Al Muderis, M.
KNEE, 2015     DOI:10.1016/j.knee.2015.07.002

Coxsackievirus B5 infection induces dysregulation of micrornas predicted to target known type 1 diabetes risk genes in human pancreatic islets

Kim, K. W. Ho, A. Alshabee-Akil, A. Hardikar, A. A. Kay, T. W. Rawlinson, W. D. Craig, M. E.
DIABETES, 2015     DOI:10.2337/db15-0956

The role of fenofibrate in metabolic reprogramming in hyperglycaemia and hypoxia

King, E. Chen, S. Yuan, J. Jenkins, A. Keech, A. Ng, M.
, 2015     DOI:10.1016/j.hlc.2015.06.188

Validation of a patient reported outcome measure of ovarian cancer symptoms and treatment related concerns with chemotherapy in recurrent ovarian cancer

King, M. Stockler, M. O'Connell, R. Joly, F. Lanceley, A. Hilpert, F. Okamoto, A. Aotani, E. Pignata, S. Donnellan, P. Oza, A. Avall-Lundqvist, E. Berek, J. Buizen, L. Sjoquist, K. Butow, P. Friedlander, M. Gillies, K. Martyn, J.

Validation of the measure of ovarian symptoms and treatment concerns, a patient-reported outcome measure of symptom burden and subjective benefit with chemotherapy in recurrent ovarian cancer

King, M. Stockler, M. O'Connell, R. Joly, F. Lanceley, A. Hilpert, F. Okamoto, A. Aotani, E. Pignata, S. Donnellan, P. Oza, A. Avall-Lundqvist, E. Berek, J. Buizen, L. Sjoquist, K. Gillies, K. Butow, P. Friedlander, M. GCIG Symptom Benefit Study Group, Gynecologic Cancer Intergroup,
, 2015     DOI:10.1007/s11136-015-1078-4

Trends in medical device clinical trials in Australia from 2002 to 2013

Ko, H. Hunter, K. Smith, E. Askie, L.

Changing patterns of clinical trial activity in Australia: 2005–2013

Ko, H. Hunter, K. Smith, E. Berber, S. Askie, L. Simes, J.

Variation in data structures across four international clinical trial registries

Ko, H. Smith, E. Zhang, L. Hunter, K. Tan-Koay, A. Vu, T. Sausa, R. Askie, L.

Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas

Lam, J. Lord, S. J. Hunter, K. E. Simes, R. J. Vu, T. Askie, L. M.

P3 BEP (ANZUP 1302): a randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Lawrence, N. Toner, G. Martin, A. Stockler, M. Yeung, A. Wong, N. Thomson, D. B. Gebski, V. Yip, S. King, M. Friedlander, M. Quinn, D. Tan, T.H. Chan, H. Mazhar, D. Hanning, F. Weickhardt, A. Jeffery, M. Stevanovic, A. Hovey, E. Wyld, D. Davis, I.D. Grimison, P. and on behalf of ANZUP,

The impact on overall survival of first-line gefitinib and erlotinib and of clinical factors in advanced non-small cell lung cancer with activating epidermal growth factor receptor mutations based on meta-analysis of 1,231 patients enrolled in 6 major randomized trials

Lee, C. Davies, L.C. Wu, Y.L. Mitsudomi, T. Inoue, A. Rosell, R. Zhou, C. Nakagawa, K. Throngprasert, S. Fukuoka, M. Gralla, R.J. Gebski, V. Mok, T. Yang, J.C.H.

Development and validation of a prognostic nomogram to predict overall survival in platinum-resistant ovarian cancer: An AURELIA substudy

Lee, C. Gibbs, E. Roncolato, F.T. Davies, L.C. Le Maignan, C. Meier, W. Lanza, M.A.A. Rosenberg, P. Marchetti, C. Vergote, I Witteveen, P. Bamias, A. Serra, S. Provencal, J. De Rauglaudre, G. Gebski, V Friedlander, M. Pujade-Lauraine, E

Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib

Lee, C. K. Goldstein, D. Gibbs, E. Joensuu, H. Zalcberg, J. Verweij, J. Casali, P. G. Maki, R. G. Cioffi, A. McArthur, G. Lord, S. J. Yip, D. Kanjanapan, Y. Rutkowski, P.
EUROPEAN JOURNAL OF CANCER, 2015     DOI:10.1016/j.ejca.2015.02.015

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial

Lee, C. K. Lord, S. Grunewald, T. Gebski, V. Hardy-Bessard, A. C. Sehouli, J. Woie, K. Heywood, M. Schauer, C. Vergote, I. Scambia, G. Ferrero, A. Harter, P. Pujade-Lauraine, E. Friedlander, M.
GYNECOLOGIC ONCOLOGY, 2015     DOI:10.1016/j.ygyno.2014.09.017

Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis

Lee, Chee Khoon Wu, Yi-Long Ding, Pei Ni Lord, Sarah J. Inoue, Akira Zhou, Caicun Mitsudomi, Tetsuya Rosell, Rafael Pavlakis, Nick Links, Matthew Gebski, Val Gralla, Richard J. Yang, James Chih-Hsin
JOURNAL OF CLINICAL ONCOLOGY, 2015     DOI:10.1200/jco.2014.58.1736